Health
Cancer Drugs to Get Cheaper: Trade Margin Capped at 30% of MRP
NPPA has approved in principle a 30% trade margin cap on non-scheduled anti-cancer drugs, a move expected to cut prices by up to 70% and save patients about Rs 2,500 crore a year.